Resource Ventures, Inc. (OTCMKTS:REVI) Looks Worn-Out
Resource Ventures, Inc. (OTCMKTS:REVI) had another day in the red, a very much expected event, but now the question is where the ticker would go from now on- whether it would regain some position on bargain buying, or sink down to its previous lows. On Monday, REVI started the week by wiping out more than 37% to $0.039, on dollar volumes above $907,000. 
With that day of reversal, REVI indeed proved that the recent climb was the work of promoters much more than an indicator of the company’s intrinsic value or future expectations. The promotional efforts ceased last week, and it is unknown if REVI will be able to attract investors without posting more updates and outlooks on its future as a marijuana company.
While REVI managed to gain a net of nearly 800%, the company reveals more and more red flags. For one, its contact address happens to be a residential area in California, a family property at the end of a road, so far not listed for sale.
Also, the partnership with Hemp, Inc. (OTCMKTS:HEMP) turns out to be a consultancy contract, and not a real agreement for a new product or method. According to HEMP, its services will include advice on “sales and marketing strategy, press releases, public company venues and overall general industry specific business guidance”, which could mean anything, especially when it comes to press releases.
For the services, HEMP will receive an initial fee of 30 million REVI shares, plus 10 million shares each quarter, for the contract term of three years. The amount may not be large compared to REVI‘s outstanding shares- above 327 million.
What is even stranger is that REVI is outright pleased in its PR that its stock price jumped by 800%. And the previous press release admitted that one of the reasons to take up the medical marijuana is the “stock feeding frenzy” on the OTC market. With that blatant admission that REVI was all about the stock jump, this ticker starts to look even more worrying.
Still, REVI is not the complete OTC market disaster. Health Sciences Group, Inc. (OTCMKTS:HESG) recently boomed to prominence, all in the triple-zero range. This stock was pure speculation, which managed to grow by 400% on sudden interest, only to crash by half back to $0.0004. HESG had many more hidden underwater rocks such as missing and patchy financial information, as well as a history of dishonest trading practices.
If you still see REVI as a bargain, keep in mind that the best days seem to be over, and too many negative details have surfaced since this newly-minted marijuana company crashed the party. While other more solid-looking companies are also not immune to sharp drops, REVI is now especially vulnerable.
